SCHEMBL5199766

SCHEMBL5199766

Cc1cccc(-c2[nH]c(C(C)C)nc2-c2cccc(-c3ccc(S(=O)(=O)N(C)C)cc3)c2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 10/20 0.44
KDM4E B2RXH2 2/20 0.40
MTOR P42345 1/20 0.39
MAPK14 Q16539 7/20 0.38
RIPK2 O43353 2/20 0.38
ACVR1B P36896 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
HSD17B10 Q99714 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
GFER P55789 1/20 0.36
LRRK2 Q5S007 2/20 0.35
CYP3A4 P08684 1/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199968 0.89 TGFBR1 (0.46) TGFBR1KDM4EMTORMAPK14RIPK2
SCHEMBL5200026 0.88 TGFBR1 (0.46) TGFBR1KDM4EMTORMAPK14RIPK2
SCHEMBL5200092 0.86 TGFBR1 (0.46) TGFBR1KDM4EMTORMAPK14RIPK2
SCHEMBL5199866 0.84 TGFBR1 (0.48) TGFBR1KDM4EMTORMAPK14RIPK2
SCHEMBL5199615 0.83 TGFBR1 (0.45) TGFBR1KDM4EMTORMAPK14RIPK2
SCHEMBL5198218 0.82 LRRK2 (0.45) TGFBR1KDM4EMTORLRRK2KDR
SCHEMBL5199931 0.82 TGFBR1 (0.48) TGFBR1KDM4EMTORMAPK14
SCHEMBL5199441 0.82 TGFBR1 (0.47) TGFBR1KDM4EMTORMAPK14RIPK2
SCHEMBL5201273 0.82 TGFBR1 (0.47) TGFBR1KDM4EMTORMAPK14RIPK2
SCHEMBL5200009 0.82 TGFBR1 (0.46) TGFBR1KDM4EMTORMAPK14RIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 TGFBR1 40/4885KDM4E 806/4885MTOR 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.